CBC News
@CBCNews·4.7M subscribers·47K videos
One million courses of therapeutic drug 'slated for delivery' to Canada this year: Pfizer
Posted
January 18, 2022
Views
13,503
Likes
52
Comments
79
Engagement
January 18, 2022
13,503
52
79
0.97%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
8:09Now PlayingPfizer Canada's Kevin Mohamed joined Power & Politics Monday to discuss the Canadian delivery schedule for its COVID-19 therapeutic drug Paxlovid, which received Health Canada approval today.
»»» Subscribe to CBC News to watch more videos
Connect with CBC News Online:
For breaking news, video, audio and indepth coverage
Find CBC News on Facebook
Follow CBC News on Twitter
For breaking news on Twitter
Follow CBC News on Instagram
Subscribe to CBC News on Snapchat
Download the CBC News app for iOS
Download the CBC News app for Android
»»»»»»»»»»»»»»»»»»
For more than 75 years, CBC News has been the source Canadians turn to, to keep them informed about their communities, their country and their world. Through regional and national programming on multiple platforms, including CBC Television, CBC News Network, CBC Radio, CBCNews.ca, mobile and on-demand, CBC News and its internationally recognized team of award-winning journalists deliver the breaking stories, the issues, the analyses and the personalities that matter to Canadians.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
